| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Aging | 2 | 2020 | 140 | 1.220 |
Why?
|
| Keratinocytes | 12 | 2019 | 790 | 1.200 |
Why?
|
| Dermatologic Agents | 2 | 2020 | 313 | 1.010 |
Why?
|
| Skin Neoplasms | 11 | 2024 | 5811 | 0.870 |
Why?
|
| Receptor, Notch1 | 6 | 2014 | 496 | 0.860 |
Why?
|
| Keratosis, Seborrheic | 2 | 2015 | 27 | 0.840 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2015 | 106 | 0.820 |
Why?
|
| Y-Box-Binding Protein 1 | 2 | 2021 | 41 | 0.800 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2024 | 4021 | 0.630 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2016 | 2916 | 0.560 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 410 | 0.490 |
Why?
|
| Skin | 4 | 2024 | 4472 | 0.480 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2013 | 1135 | 0.470 |
Why?
|
| S100 Proteins | 7 | 2003 | 217 | 0.440 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2447 | 0.420 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 276 | 0.400 |
Why?
|
| Ultraviolet Rays | 3 | 2020 | 1079 | 0.400 |
Why?
|
| Copper | 6 | 2007 | 367 | 0.390 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 2222 | 0.380 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1614 | 0.380 |
Why?
|
| Fibroblast Growth Factor 1 | 7 | 2007 | 56 | 0.360 |
Why?
|
| Signal Transduction | 18 | 2024 | 23415 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 2821 | 0.330 |
Why?
|
| Antineoplastic Agents | 6 | 2020 | 13635 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2456 | 0.280 |
Why?
|
| Calcium-Binding Proteins | 7 | 2004 | 1066 | 0.270 |
Why?
|
| Stem Cells | 3 | 2019 | 3514 | 0.270 |
Why?
|
| Cell Survival | 2 | 2015 | 5780 | 0.270 |
Why?
|
| Interleukin-1 | 3 | 2003 | 1248 | 0.250 |
Why?
|
| Apoptosis | 11 | 2021 | 9476 | 0.240 |
Why?
|
| Transcription Factors | 5 | 2019 | 12116 | 0.240 |
Why?
|
| Stress, Physiological | 3 | 2013 | 1403 | 0.220 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2024 | 141 | 0.210 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 11874 | 0.210 |
Why?
|
| Small Molecule Libraries | 3 | 2016 | 733 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 3 | 2015 | 1132 | 0.190 |
Why?
|
| Mice | 32 | 2024 | 81368 | 0.180 |
Why?
|
| Proteome | 1 | 2010 | 1857 | 0.180 |
Why?
|
| Standard of Care | 1 | 2024 | 551 | 0.180 |
Why?
|
| Cells, Cultured | 10 | 2019 | 18937 | 0.180 |
Why?
|
| Esophageal Neoplasms | 1 | 2010 | 1657 | 0.170 |
Why?
|
| Chelating Agents | 4 | 2007 | 387 | 0.170 |
Why?
|
| Phosphatidylserines | 2 | 2015 | 188 | 0.170 |
Why?
|
| Fibroins | 1 | 2020 | 57 | 0.170 |
Why?
|
| Animals | 42 | 2024 | 168202 | 0.170 |
Why?
|
| Skin Physiological Phenomena | 1 | 2020 | 188 | 0.160 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2024 | 557 | 0.160 |
Why?
|
| Quinolines | 1 | 2024 | 764 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2016 | 2803 | 0.160 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2013 | 1626 | 0.150 |
Why?
|
| Membrane Proteins | 6 | 2015 | 7847 | 0.150 |
Why?
|
| Molybdenum | 4 | 2007 | 46 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 560 | 0.150 |
Why?
|
| Chemokine CXCL1 | 1 | 2018 | 101 | 0.150 |
Why?
|
| Cosmetic Techniques | 1 | 2020 | 148 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2020 | 712 | 0.140 |
Why?
|
| Interleukin-8 | 2 | 2018 | 696 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2012 | 8542 | 0.140 |
Why?
|
| Indenes | 1 | 2017 | 59 | 0.140 |
Why?
|
| Proteomics | 1 | 2010 | 3836 | 0.140 |
Why?
|
| Naphthoquinones | 1 | 2016 | 58 | 0.140 |
Why?
|
| Cell Differentiation | 6 | 2018 | 11512 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 2013 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3794 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 988 | 0.130 |
Why?
|
| Indole Alkaloids | 1 | 2015 | 23 | 0.130 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 516 | 0.130 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 83 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 153 | 0.120 |
Why?
|
| Epidermis | 1 | 2018 | 526 | 0.120 |
Why?
|
| Cell Line, Tumor | 12 | 2019 | 16968 | 0.120 |
Why?
|
| Benzoates | 1 | 2016 | 212 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 3 | 2016 | 933 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 774 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 927 | 0.120 |
Why?
|
| Humans | 47 | 2024 | 760740 | 0.110 |
Why?
|
| Benzamides | 1 | 2019 | 1371 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2014 | 433 | 0.110 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 3419 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 645 | 0.110 |
Why?
|
| Endoribonucleases | 1 | 2015 | 228 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 2 | 2003 | 2644 | 0.110 |
Why?
|
| Podocytes | 1 | 2017 | 405 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 5369 | 0.110 |
Why?
|
| Disulfides | 1 | 2015 | 464 | 0.110 |
Why?
|
| rho-Associated Kinases | 2 | 2013 | 281 | 0.110 |
Why?
|
| Wound Healing | 1 | 2024 | 2802 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2017 | 878 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2016 | 1320 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2016 | 548 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2021 | 1094 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 1670 | 0.100 |
Why?
|
| Coronary Restenosis | 2 | 2006 | 396 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1492 | 0.100 |
Why?
|
| Melanins | 1 | 2014 | 289 | 0.100 |
Why?
|
| Skin Pigmentation | 1 | 2014 | 277 | 0.100 |
Why?
|
| Dioxolanes | 1 | 2011 | 23 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2013 | 2872 | 0.100 |
Why?
|
| Psoriasis | 1 | 2019 | 944 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3868 | 0.090 |
Why?
|
| beta Catenin | 1 | 2016 | 1039 | 0.090 |
Why?
|
| DNA-Binding Proteins | 4 | 2019 | 9586 | 0.090 |
Why?
|
| Nitrogen Isotopes | 1 | 2010 | 84 | 0.090 |
Why?
|
| Immunity | 1 | 2016 | 994 | 0.090 |
Why?
|
| Oncogenes | 1 | 2016 | 1220 | 0.090 |
Why?
|
| NIH 3T3 Cells | 4 | 2007 | 669 | 0.090 |
Why?
|
| Melanocytes | 1 | 2014 | 509 | 0.090 |
Why?
|
| Carbon Isotopes | 1 | 2010 | 458 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2018 | 2929 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 1738 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2015 | 1526 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2016 | 1977 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2021 | 10429 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3245 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2010 | 392 | 0.080 |
Why?
|
| Protein Binding | 3 | 2018 | 9345 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4340 | 0.080 |
Why?
|
| Microscopy, Confocal | 5 | 2005 | 1970 | 0.080 |
Why?
|
| Thapsigargin | 2 | 2017 | 102 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2015 | 5034 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3599 | 0.080 |
Why?
|
| Lactams | 1 | 2009 | 156 | 0.080 |
Why?
|
| Drug Discovery | 2 | 2013 | 1051 | 0.070 |
Why?
|
| Cytosol | 2 | 2003 | 886 | 0.070 |
Why?
|
| Pyridines | 1 | 2019 | 2875 | 0.070 |
Why?
|
| Calcium | 3 | 2008 | 5717 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2008 | 2851 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2527 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2017 | 2008 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4110 | 0.070 |
Why?
|
| Biological Products | 1 | 2016 | 912 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 475 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2090 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 982 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 2137 | 0.070 |
Why?
|
| Lactones | 1 | 2009 | 316 | 0.070 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2004 | 191 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 1727 | 0.070 |
Why?
|
| Receptors, Notch | 3 | 2006 | 743 | 0.070 |
Why?
|
| Wnt1 Protein | 1 | 2006 | 121 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 3611 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3527 | 0.060 |
Why?
|
| Neoplasms | 2 | 2013 | 22131 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1185 | 0.060 |
Why?
|
| Cell Nucleus | 4 | 2011 | 2894 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4392 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3115 | 0.060 |
Why?
|
| Actins | 4 | 2000 | 2051 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 433 | 0.060 |
Why?
|
| Autophagy | 1 | 2013 | 1327 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11069 | 0.060 |
Why?
|
| HCT116 Cells | 2 | 2015 | 403 | 0.060 |
Why?
|
| Amino Acids | 1 | 2010 | 1718 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 169 | 0.060 |
Why?
|
| Mevalonic Acid | 1 | 2024 | 46 | 0.060 |
Why?
|
| Cytoskeleton | 2 | 1999 | 1170 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 768 | 0.060 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2024 | 97 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2015 | 3606 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2189 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3705 | 0.050 |
Why?
|
| Myocardium | 3 | 2001 | 4725 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 278 | 0.050 |
Why?
|
| U937 Cells | 1 | 2003 | 261 | 0.050 |
Why?
|
| Mutation | 4 | 2021 | 30015 | 0.050 |
Why?
|
| Mice, Knockout | 5 | 2024 | 14388 | 0.050 |
Why?
|
| Membrane Glycoproteins | 4 | 2014 | 3688 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 1056 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5304 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2015 | 717 | 0.050 |
Why?
|
| Extracellular Fluid | 1 | 2003 | 165 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2008 | 3088 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 730 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 1754 | 0.050 |
Why?
|
| Pancreatitis, Chronic | 1 | 2024 | 288 | 0.050 |
Why?
|
| Cell Line | 4 | 2016 | 15577 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3776 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8700 | 0.050 |
Why?
|
| Porins | 1 | 2000 | 78 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 578 | 0.040 |
Why?
|
| Temperature | 2 | 2007 | 2224 | 0.040 |
Why?
|
| Myocardial Stunning | 1 | 2000 | 66 | 0.040 |
Why?
|
| Caspase 8 | 2 | 2013 | 190 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3619 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3447 | 0.040 |
Why?
|
| Yeasts | 1 | 2000 | 278 | 0.040 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2000 | 163 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 2100 | 0.040 |
Why?
|
| 5-Methylcytosine | 1 | 2019 | 147 | 0.040 |
Why?
|
| 3T3 Cells | 3 | 2009 | 1085 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2021 | 703 | 0.040 |
Why?
|
| DNA Damage | 4 | 2011 | 2445 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 592 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2445 | 0.040 |
Why?
|
| Histone Code | 1 | 2019 | 158 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2000 | 422 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2000 | 302 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 2019 | 265 | 0.040 |
Why?
|
| Proteins | 2 | 2004 | 6030 | 0.040 |
Why?
|
| Synaptotagmin I | 3 | 2003 | 33 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2005 | 3680 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1998 | 163 | 0.040 |
Why?
|
| Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 1483 | 0.040 |
Why?
|
| Protein Transport | 4 | 2007 | 1966 | 0.040 |
Why?
|
| Gammaproteobacteria | 1 | 2017 | 28 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2001 | 481 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 483 | 0.040 |
Why?
|
| Camptothecin | 1 | 2021 | 591 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 531 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6188 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2003 | 1112 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 1088 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2019 | 2916 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2019 | 344 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2011 | 2985 | 0.040 |
Why?
|
| Bignoniaceae | 1 | 2016 | 4 | 0.040 |
Why?
|
| Ericaceae | 1 | 2016 | 4 | 0.040 |
Why?
|
| Smegmamorpha | 1 | 2016 | 12 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5672 | 0.030 |
Why?
|
| Breast | 1 | 2006 | 1963 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 373 | 0.030 |
Why?
|
| Acetylation | 1 | 2019 | 1055 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1404 | 0.030 |
Why?
|
| Carnitine | 1 | 1997 | 252 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2000 | 907 | 0.030 |
Why?
|
| Jejunum | 1 | 1998 | 472 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 3 | 2003 | 4408 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2001 | 1092 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 619 | 0.030 |
Why?
|
| Myoblasts | 1 | 2016 | 231 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4910 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14649 | 0.030 |
Why?
|
| Ceruloplasmin | 2 | 2006 | 56 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3095 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2021 | 2224 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9461 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 495 | 0.030 |
Why?
|
| Stents | 1 | 2006 | 3177 | 0.030 |
Why?
|
| Kinetics | 2 | 2000 | 6370 | 0.030 |
Why?
|
| Monophenol Monooxygenase | 1 | 2014 | 72 | 0.030 |
Why?
|
| Phenotype | 2 | 2009 | 16572 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2014 | 105 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6126 | 0.030 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2013 | 88 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9417 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3591 | 0.030 |
Why?
|
| Synaptotagmins | 2 | 2003 | 53 | 0.030 |
Why?
|
| Tunica Intima | 2 | 2006 | 458 | 0.030 |
Why?
|
| Inflammation | 3 | 2024 | 10759 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 17630 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 866 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 282 | 0.030 |
Why?
|
| Microscopy, Electron | 3 | 2000 | 2561 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 20077 | 0.030 |
Why?
|
| Cell Death | 1 | 2017 | 1677 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1226 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 146 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2014 | 259 | 0.020 |
Why?
|
| Cell Movement | 1 | 2004 | 5201 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2014 | 412 | 0.020 |
Why?
|
| Comet Assay | 1 | 2011 | 75 | 0.020 |
Why?
|
| Phagosomes | 1 | 2013 | 199 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 724 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1333 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1836 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 791 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18220 | 0.020 |
Why?
|
| Thiophenes | 1 | 2015 | 569 | 0.020 |
Why?
|
| Myocardial Ischemia | 2 | 2000 | 2110 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 5789 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2013 | 8311 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2001 | 317 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 561 | 0.020 |
Why?
|
| Aorta | 1 | 1998 | 2041 | 0.020 |
Why?
|
| Base Sequence | 3 | 2007 | 12420 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1336 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 1788 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 9526 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22117 | 0.020 |
Why?
|
| Dipeptides | 1 | 2011 | 391 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 13442 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4739 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 1989 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2016 | 1350 | 0.020 |
Why?
|
| Female | 6 | 2024 | 392203 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1454 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9171 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2013 | 5433 | 0.020 |
Why?
|
| Receptors, Death Domain | 1 | 2007 | 31 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2011 | 616 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 4512 | 0.020 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 2802 | 0.020 |
Why?
|
| Caffeine | 1 | 2011 | 699 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1650 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2011 | 20988 | 0.020 |
Why?
|
| Chelation Therapy | 1 | 2006 | 77 | 0.020 |
Why?
|
| Heart | 1 | 1999 | 4403 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1894 | 0.020 |
Why?
|
| Transfection | 2 | 2004 | 5765 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2533 | 0.020 |
Why?
|
| Cell Communication | 1 | 2013 | 1654 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 5780 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2007 | 4140 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2007 | 367 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 237 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2011 | 1606 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3045 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 2003 | 68 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 427 | 0.010 |
Why?
|
| Stress Fibers | 1 | 2004 | 55 | 0.010 |
Why?
|
| Rabbits | 2 | 2001 | 4770 | 0.010 |
Why?
|
| Male | 7 | 2024 | 360402 | 0.010 |
Why?
|
| Models, Structural | 1 | 2003 | 340 | 0.010 |
Why?
|
| Focal Adhesions | 1 | 2004 | 115 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2012 | 2481 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2005 | 740 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2006 | 749 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2238 | 0.010 |
Why?
|
| Swine | 2 | 2006 | 5908 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2004 | 257 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6520 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4172 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 2817 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4269 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2413 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 389 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 656 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2001 | 125 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2001 | 339 | 0.010 |
Why?
|
| beta Karyopherins | 1 | 2000 | 46 | 0.010 |
Why?
|
| Nuclear Localization Signals | 1 | 2000 | 77 | 0.010 |
Why?
|
| Detergents | 1 | 2001 | 236 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29601 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 2000 | 150 | 0.010 |
Why?
|
| Macrophages | 1 | 2015 | 5758 | 0.010 |
Why?
|
| Myofibrils | 1 | 2001 | 141 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1692 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1989 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 434 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 460 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 890 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2006 | 12759 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1662 | 0.010 |
Why?
|
| Dictyostelium | 1 | 1999 | 70 | 0.010 |
Why?
|
| Biopolymers | 1 | 2000 | 183 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 460 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 4117 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2001 | 369 | 0.010 |
Why?
|
| Vimentin | 1 | 1999 | 255 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 1496 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1999 | 241 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1999 | 944 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1999 | 574 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 836 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12977 | 0.010 |
Why?
|
| Cysteine | 1 | 2001 | 891 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2000 | 1540 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1999 | 646 | 0.010 |
Why?
|
| Troponin | 1 | 1999 | 502 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 23716 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4457 | 0.010 |
Why?
|
| Tubulin | 1 | 1999 | 692 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 2231 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1999 | 2467 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4470 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5863 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 3074 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 1999 | 2063 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 3672 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1698 | 0.010 |
Why?
|
| Heart Failure | 1 | 1997 | 11670 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 2659 | 0.010 |
Why?
|
| Ligands | 1 | 2000 | 3268 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2000 | 3965 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 8165 | 0.010 |
Why?
|
| Time Factors | 2 | 2006 | 39908 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 2639 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2000 | 2135 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 6051 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5109 | 0.000 |
Why?
|
| Cytokines | 1 | 2003 | 7373 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 3873 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 4947 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 8998 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 74128 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 220995 | 0.000 |
Why?
|